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Summary 
The kk gene encodes a lymphocyte-specific  protein tyrosine kinase of the nonreceptor type that 
is implicated in signal transduction pathways emanating from the CD4 and CD8 coreceptors. 
Previous studies also support a role for p56  kk in regulating T cell receptor/~ gene rearrangements 
and, more generally,  thymocyte development. Here we report that a mutant form of p56  ~k, 
which is incapable of interacting with CD4 or CD8, behaves indistinguishably from association- 
competent p56  ~k with respect to its ability to affect thymocyte maturation. The effects of p56  ~k 
remained specific in that the closely related src-family kinase p59  ~k was incapable of substituting 
for p56  ~  in arresting ~ locus gene rearrangements. These data support the view that src-family 
kinases perform highly specialized and often nonoverlapping functions in hematopoietic cells, 
and that p56  kk acts independently of its association with CD4 and CD8 to regulate thymocyte 
development. 
T 
he p56  "k signaling molecule is  a  509  residue src-like 
protein tyrosine kinase that is expressed almost exclu- 
sively in T  lymphocytes (1-3).  Originally identified as the 
product of a gene that was activated by retroviral insertion 
in certain murine lymphoid cell lines (1, 4), the kk gene is 
expressed in thymocytes from the time that hematopoietic 
progenitors first colonize the thymic anlage,  and kk tran- 
scripts accumulate in all thymocyte subsets  and all mature 
T cell populations (1, 2, 5-7). Involvement of p56  ~k in lym- 
phocyte signaling was suggested by the ability of mutant ac- 
tivated  forms  of this  protein,  those  lacking a  conserved 
COOH-terminal tyrosine phosphorylation site (Y505),  to 
transform both fibroblasts in vitro (8, 9) and lymphoid cells 
in transgenic mice (10). Moreover, p56  ~ physically associates 
with the CD4 and CD8 coreceptor structures on T lympho- 
cytes (11-13), and becomes activated when CD4 is crosslinked 
using anti-CD4 antibodies (14-16).  Paired cysteine residues 
in the NHz-terminal domain of p56  kk, and in the short in- 
tracellular segments of both CD4 and CD8, are required for 
this  association  (17, 18). In  one  study,  transfection of a 
lysozyme-specific  T  cell hybridoma that requires  CD4 for 
antigen recognition with constructs encoding a CD4 mole- 
cule lacking these cysteine residues resulted in loss of CD4 
signaling capacity (19). These observations, in aggregate, have 
given weight to the hypothesis that antigen recognition by 
T cells is potentiated when the CD4 or CD8 coreceptor struc- 
ture becomes associated with the antigen receptor complex, 
thereby approximating the p56  ~k kinase to  the CD3  sig- 
naling machinery (20). 
Whereas p56  ~k almost certainly serves a crucial function 
in relaying signals from coreceptor molecules, there are many 
circumstances in which the signaling capacity of p56  ~  ap- 
pears unrelated to CD4 and CD8 expression.  For example, 
p56  ~k is expressed at high levels in NK cells (2, 6, 21, 22), 
where CD4 and CD8 do not participate in antigen recogni- 
tion. Moreover, lck transcripts accumulate to the greatest ex- 
tent in thymocytes, including CD4-8-  thymocytes (2, 5-7). 
In  one  set  of experiments, expression  of activated  p56  ~k 
(bearing a phenylalanine residue at position 505) in an insnlin- 
reactive T cell line yielded cells with a much increased sensi- 
tivity to antigen, despite the fact that these cells failed to 
express CD4 or CD8 (23). A more recent study demonstrated 
that loss of p56  ~k expression  in the CD4-8-  transformed 
human T cell line Jurkat resulted in a nearly complete block 
in TCR-mediated signaling which could be reconstituted by 
expression  of wild-type p56  ~k (24).  These results suggest 
that p56  kk may contribute to T cell signaling pathways other 
than those that emanate from the CD4-and CD8 receptors. 
Consistent with this view, p56  kk has been shown to associate 
with the/~ chain of the IL-2 receptor, and becomes activated 
after IL-2 treatment of normal T  cells (25,  26). 
Previous studies demonstrate that thymocyte development 
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bearing a targeted disruption of the kk  gene (27),  or ex- 
pressing high levels of a dominant-negative form of p56 ~k 
(28), manifest a severe  block in thymocyte  maturation resulting 
in a 20-50-fold reduction in thymocyte number, primarily 
as a result of decreased  generation of CD4+8 + cells from 
CD4-8-  precursors. 
Augmented expression  of p56 ~k in transgenic mice under 
the control of its own promoter provided more insight into 
this phenomenon. Mice expressing very high levels of p56 ~k, 
and especially those expressing the mutant (F505) activated 
form, rapidly develop thymic tumors, supporting the view 
that p56  ~i activity promotes mitogenesis (10). More impor- 
tantly, even modest overexpression  of p56  ~  yields thymo- 
cytes in which TCR gene rearrangement no longer follows 
the normal developmental sequence. In these animals, joining 
of VB gene segments to D~ gene segments fails to occur, 
even though Voe to Joe rearrangement, ordinarily a later event, 
proceeds normally (29,  30).  These observations support a 
model in which p56  ~k serves to regulate rearrangement at 
the 3 locus, perhaps by perceiving the correct expression  of 
a CB-containing gene product (30). 
In principle, the signaling disturbances that occur in mice 
expressing  high  levels  of p56  ~k  could  reflect  delivery of 
signals  from  the  CD4/CD8  coreceptors,  from  the  IL-2 
receptor, or from some other receptor structure. To elucidate 
the nature of this signaling pathway, we have generated trans- 
genie mice in which the same construct previously employed 
to express high levels of p56  ~k in thymocytes was modified 
to permit expression of a mutant form of p56  ~k that cannot 
interact with CD4 or CD8, and have examined the effects 
of simultaneous overexpression  of wild-type CD4 in both 
animal systems. We have also expressed an activated version 
of a closely related protein tyrosine kinase, p59  ~'k, in thymo- 
cytes using the same thymocyte-specific  promoter. Examina- 
tion of these animals reveals that interaction with CD4 is 
not required to permit elaboration of an/ck-overexpression 
phenotype, and indeed CD4 actually appears to "sequester" 
p56 ~k and render it less potent. Our results provide strong 
support for the proposition that p56  ~k regulates thymocyte 
development independently of its ability to interact with CD4 
and CD8, and does so uniquely, in that closely related ki- 
nases, expressed in activated forms and at high levels, cannot 
mimic its effects. 
Materials  and Methods 
Transgene Expression Vector  and Transgenic Mouse Production.  The 
pkkFS05 expression vector has been described dsewhere (10, 29). 
Site-directed mutagenesis (31) was used to convert cysteine  codons 
20 and 23 to ahnine codons (codon 20 changed from TGT to GCC 
and codon 23 changed from TGC to GCG). The mutagenesis was 
carried out on a kk eDNA. After confirming the presence of the 
mutation and the absence of other changes by DNA sequencing 
(32), a 125-bp StuI/BgllI fragment containing the mutation was 
isolated and substituted for the corresponding wild-type fragment 
in pkkF505 (29). An 11.2-kb XhoI/NotI fragment was then purified 
on low malting point agarose gels and injected into C57BL/6J  x 
DBA/2 F2 zygotes to generate transgenic mice. 
The p1017 vector has been described (33, 34), as has a human 
hck eDNA in which site-directed mutagenesis was employed to 
convert tyrosine codon 501 to a phenylalanine codon (35). The 
hckFS01 eDNA was purified as an EcolLl fragment, made blunt- 
ended using T4 DNA polymerase, and ligated into p1017 at the 
BamHI site which was also filled-in using T4 DNA polymerase. 
A 7-kb NotI fragment was excised  and used to generate transgenic 
mice as above. 
Transgene-bearing animals were identified by hybridization to 
a probe for the human growth hormone 3' region (10, 29). Tram- 
genie lines were created by crossing founders to C57BL/6J mice 
(The Jackson Laboratory, Bar Harbor, ME). 
Flow Cytoraetry.  Lymphocyte suspensions were generated by 
compression of  lymphoid organs between ground glass slides. RBC 
were lysed using NH4C1 lysis as previously described (29), Lym- 
phocytes recovered  were counted on a hemocytometer and stained 
for surface  expression of  CD4 (PE-conjugated  GK1.5; Becton Dick- 
inson & Co., Mountain View, CA), CD8 (FITC-conjugated 53- 
6.71; Becton Dickinson & Co.), CD3e (biotinylated 500AA2, ref- 
erence 36; or FITC-conjugated 145-2Cll,  reference 37), or Thy 
1.2 (biotinylated 30-H12; Becton Dickinson & Co.). Detection of 
biotinylated  antibodies  was facilitated  by PE-conjugated  streptavidin 
(Caltag Laboratories, San Francisco, CA). Multi-parameter flow 
cytometric  analysis  was carried  out on a FACScan  |  cell  sorter (Becton 
Dickinson & Co.). 
Immunoblot Analysis.  Whole cell lysates were generated by 
solubilizing thymocytes in TNT buffer (150 mM NaC1, 50 mM 
Tris-C1 [pH, 8], 1% Triton X-100, I mM NaVO4, 1 mM PMSF) 
for 20 min at 4~  Insoluble material was removed  by centrifuging 
at 12,000 g for 5 rain at 4~  Lysates  were then boiled in SDS 
sample buffer, resolved on 10%  (p56  ~) or  12%  (p59  ~k) SDS- 
PAGE, and transferred to nitrocellulose. For p56  ~ and p59  h'~ de- 
tection, filters were blocked in 5% milk, 0.1% Tween 20. Rabbit 
polyclonal antisera specific  for p56 ~ (195.7; 38) or p59  *'~ (6168.2; 
35) were used at a concentration  of 1:5,000 in 1% milk, 0.1% Tween 
20. After a 2-h incubation at room temperature, the filters were 
rinsed in 1% milk, 0.1% Tween 20, and developed using a donkey 
anti-rabbit  secondary antibody and the Enhanced Chemilumi- 
nesence detection system  (Amersham  Corp., Arlington Heights, IL). 
Imraunoprecipitations and In Vitro Kinase Assay.  Immunoprecipi- 
tations of  kinases  were performed using the same antisera  described 
above at a 1:200 dilution from 10-100/~g of total thymocyte pro- 
tein. Anti-CD4 immunoFrecipitates  were performed  using the mAb 
GK1.5 plus a rabbit anti-rat IgG secondary  antibody. Immune com- 
plexes were collected  using Pansorbin (Calbiochem-Novabiochem, 
La  JoUa, CA). Pellets  were washed  five  times in TNT and two times 
in high salt TNT (1 M NaC1), and resuspended in kinase buffer 
(20 mM Tris-C1 [pH, 7.5], 10 mM MnCh, 1 mM NazVO4, 0.1% 
Triton  X-100,  plus 2  #1  per  reaction  of qr-[32P]ATP (3,000 
Ci/mmol). These reactions were allowed to proceed for 10 rain 
at room temperature, and were stopped by addition of SDS sample 
buffer and by boiling for 3 rain before resolution on SDS-PAGE. 
Gels were dried and exposed to X-ray film. 32p incorporation into 
protein bands was determined on a Phosphorlmager  |  (Molecular 
Dynamics, Sunnyvale, CA). 
Quantitation of raRNA Levels by Northern and Slot Blots.  KNA 
was prepared according to the method of Chomczynski and Sacchi 
(39) and resolved on 1% agarose formaldehyde  gels (40) or exam- 
ined using a slot blotting apparatus (Schleicher & SchueU, Inc., 
I~ene, NH). Blots were probed with 32p-labeled probes generated 
from human growth hormone sequences, from kk or hck eDNA, 
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performed using scanning densitometry (10, 29). 
Detection of/9  Chain Rearrangements by PCR  and Northern 
Blot.  The  synthetic  oligonucleotides,  PCR  amplification, gel 
transfer, probes, and blot hybridization conditions were performed 
as described previously (30). Northern blots were prepared as de- 
scribed above, but were probed with 32p-labded C/~ or Cc~ probes 
as described (30). 
Results 
Expression of  a CD4  /CD8 Association-Defecti~  kkFS05 Trans- 
gene.  To investigate the possibility that p56 ~k might act in- 
dependently of CD4 and CD8 in blocking thymocyte matu- 
ration, we constructed a transgene that was identical to the 
kkFS05 transgene employed previously (10, 29;  Fig.  1 A), 
but which also had alanine codons substituted for cysteine 
codons 20 and 23 (Fig.  1 B). Substitution of a phenylalanine 
codon for tyrosine at position 505 yields an "activated" ver- 
sion of p56 ~  that exhibits a 3-7-fold greater potency than 
does its wild-type counterpart (10, 29).  Previous work has 
demonstrated that the alanine substitutions at positions 20 
and 23 eliminate the ability of p56 ~k to couple to CD4 and 
CD8 (17 and see below). Hence the kkFSO5A20,23 trans- 
gene product should be activated, by virtue of the F505 mu- 
tation, but unable to interact with CD4 or CD8, because 
of the A20/A23 substitutions. This transgene should there- 
fore provide information regarding CD4/CD8-dependent and 
-independent kkF505  effects. 
In all,  twelve founder animals and six mouse lines were 
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Figure 1.  Transgene  expression  vectors. (,t) Structure  of the kkF505 
transgene. Exons are denoted  by numbered  boxes. The positions of the 
translation initiation and termination  codons are also noted (10, 29). (B) 
Structure of the khF505A20,23 transgene. This construct differs from 
kkF505 (,4) only in that alanine  codons  have  been substituted  for cysteine 
codons 20 and 23. (C) Structure  of the plO17hckF501  transgene. See text 
for description. 
analyzed for transgene expression and thymocyte cell surface 
phenotype (Table 1). Transgene expression was limited to the 
thymus and mRNA level were proportional to the number 
of copies integrated into the genome (data not shown), as 
was observed with the previous kkF505 construct (10, 29). 
Mice that expressed the kkFSO5A20,23 transgene at roughly 
twofold over endogenous kk mRNA levels developed thymic 
tumors (Table  1) with approximately the same kinetics as 
/ckF505  animals (10).  It is interesting that progeny of the 
7121 and 7148 founder animals developed tumors sporadi- 
cally (Table 1), suggesting that their expression levels lie near 
the threshold for tumor development (10). All tumors were 
phenotypically immature as judged by CD3, CD4, and CD8 
staining (Fig. 2) and were indistinguishable from tumors pro- 
duced in kkFS05 mice (10). We conclude from this that trans- 
forming potential of p56  ~k is independent of its ability to 
associate  with CD4 and CD8. 
In kkF505A20,23 mice that did not develop tumors, a de- 
fect in thymocyte maturation was observed that reflected an 
inability to produce CD3-bearing CD4*8 -  and CD4-8 + 
(single positive) cells (Fig. 3) although total thymocyte numbers 
were unchanged (data not shown). Instead, increased per- 
centages of CD4+8 +,  CD4-8-,  and  CD8+/CD3 -  cells 
(believed to represent precursors to CD4+8 + cells) were ob- 
served. Construction of a dose-response curve plotting trans- 
gene expression versus  the number of CD3 + cells demon- 
strated that the kkFS05 and kkFSOSA20,23 transgenes exhibit 
identical characteristics (Fig.  4). Peripheral T  cell numbers 
were also reduced in kkF505A20,23 mice, again in a manner 
that was indistinguishable from kkF505 animals (Table 1 and 
data not shown). 
The inability  to  generate CD3 + cells  in  kkF505  mice 
results primarily from a failure to rearrange V~ TCR gene 
segments, such that thymocytes from these animals contain 
1.0-kb ~  locus transcripts that result from D/~-JB joining, 
but lack mature 1.3-kb products that ordinarily reflect V/3-D/3 
rearrangement (29, 30). Fig. 5 demonstrates that this defect 
also characterizes thymocytes from kkFSO5A20,23 mice. Thus 
mature 1.3-kb B chain transcripts are not observed in de- 
veloping thymocytes from kk transgenic animals, but the 1.0- 
kb D~-J~ mRNA is readily detected (Fig.  5 A). Quantita- 
tion  of  specific  V~  to  DB-JB  rearrangements  by  PCR 
amplification of thymocyte DNA confirms a reduction in 
joining events comparable to that seen in kkF505 mice (Fig. 
5 B). DB to J~/joining events, however, were detected at levels 
comparable to those in normal thymocytes (Fig.  5 B). Fig. 
5 A  also shows that full-length o~ chain mRNA is present 
at normal levels in thymocytes from both types of transgenic 
mice. We conclude that a kk transgene product which was 
presumably unable to interact with either CD4 or CD8 pro- 
duced the same developmental abnormalities, apparently by 
a similar mechanism, as a transgene product which could phys- 
ically couple to these coreceptors. 
The IckF505A20,23 Transgene Product Does Not Immuno- 
precipitate with CD4.  One possible explanation for our ob- 
servations might be that p56 ~kFs~176  can in fact interact 
with the CD4 and CD8 coreceptors under certain circum- 
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Tumor  CD3 +  CD3 + 
Line  Number  Expression  Formation  (Thymus)  (Periphery) 
7137  1  ND  +  31.0  13 
4965  1  51.6  +  13.6  15 
5044  2  29.3  +  12.0  15 
5049  1  29.1  +  1.0  15 
7178  1  26.5  +  23.6  57 
7121  7  23.6  •  *  10.4  20 
7148  6  20.7  •  9.8  22 
7120  2  11.6  -  6.2  50 
4966  1  6.8  -  36.5  62 
5057  1  5.2  -  55.0  60 
5048  1  4.9  -  59.3  78 
5045  4  1.5  -  101  95 
4972  6  0.9  -  102  110 
4967  1  0.6  -  109  86 
Transgene  expression levels are given as pg of transgene  mKNA/#g total KNA. The mean number of CD3+  thymocytes and peripheral  T  cells 
is presented  (as percentage  of control values) for each line examined.  Tumor formation was scored by visual inspection  and increased forward light 
scatter  (indicative  of an increase in thymocyte size which typically  accompanies transformation). 
" Two out of seven animals developed  tumors in this  line. 
One out of six an/mals developed  a tumor in this line. 
stances.  For example,  our previous experiments,  and those 
of  others,  defining  the  region  of  p56  ~k  responsible  for 
coreceptor binding were performed under nonphysiological 
conditions in fibroblast cell lines (17, 18). To address the ex- 
tent of association of p56  ~Fs~176  with CD4 in lymphoid 
cells, we performed immunoprecipitation experiments using 
thymocyte extracts from normal, kkFS05, and kkFSO5A20,23 
mice. Anti-p56 ~k immunoprecipitates showed elevated kinase 
activity in both kkF505 and kkF505A20,23 extracts, consis- 
tent with overexpression of the transgenes and the enhanced 
activity associated with the F505 mutation  (Fig.  6). How- 
ever, in anti-CD4 immunoprecipitates elevated kinase activity 
was observed only in the/ckFS05 lysates. The kkFSOSA20,23 
extracts contained CD4-associated kinase activity at about 
the levels  seen in normal  animals  (Fig.  6).  This  suggested 
that  only endogenous wild-type p56  ~k was coupling with 
CD4 in/ckFS05A20,23  lysates in  this in vitro assay. 
Rescue of lckF505 Transgene Effects by Expression of a CD4 
~ansgen~  Additional in vivo experiments permitted a much 
more persuasive  test of the interaction of p56  ~kFs~176  with 
CD4  and  provided  further  evidence  of  the  coreceptor- 
independent  nature of the kk transgene  effects.  Previously 
we reported the generation of lines of transgenic mice that 
express high levels of mouse CD4 under the control of the 
/ck proximal promoter  (41).  If overexpression of p56  ~k in- 
terferes  with  thymocyte development  through  overzealous 
delivery of a coreceptor-derived signal, we reasoned that simul- 
taneous overexpression of CD4 and kk might yield additive 
effects.  We therefore crossed kkF505 transgenic  mice with 
/ck-CD4 mice (line 727), the thymocytes of which  all ex- 
press very high levels  of CD4  (about  15-fold over normal 
CD4 levels seen in CD4 +  8 + cells).  The/ck-CD4 transgenic 
mice normally exhibit no defects in TCR gene rearrange- 
ments (data not shown), although the level of CD3 expres- 
sion in immature  CDY  ~  cells is increased somewhat (41). 
Comparison  of the  number  of CD3 +  cells  in  progeny 
from this cross revealed a remarkable recovery of CD3 + cells 
in thymuses from animals carrying both transgenes, as com- 
pared with thymuses from animals transgenic for kkF505 alone 
(Fig.  7).  In three kkF505 lines tested,  coexpression of the 
CD4 transgene resulted in recovery of substantial numbers 
of CD3 + cells. Hence, it appeared that excess CD4 mitigated, 
to some extent, the effects of the kkF505 transgene, perhaps 
by binding  and sequestering the excess p56 ~k. 
However, it was also possible that signals derived from the 
overexpressed CD4 product, though essentially undetectable 
themselves,  actually  acted  independently  of p56  ~k to  an- 
tagonize the effects of the kinase.  This explanation could be 
excluded by examining the maturation  of thymocytes from 
the kkF505A20,23  mice that  also expressed high levels  of 
CD4. If the IckF505A20,23 transgene product was behaving 
as expected (i.e.,  not associating with CD4),  there should 
be no recovery of CD3 + cells despite the presence of excess 
CD4, since sequestration should not occur. Fig. 8 shows that 
this was in fact the case. No improvement in the representa- 
tion  of  CD3-bearing  cells  was  observed  in  the  double- 
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Figure 2.  Properties  of  tumors  generated  by  overexpression  of 
kkF505A20,23. Thymocyte flow cytometric profiles from two indepen- 
dent founder animals ex~essing the kkFS05A20,23 transgene. These animals 
had developed grossly visible thymic tumors. (.4 and B) (Solid line) Cells 
from the transgenic animal; (dotted line) control cells. (,4) Forward scatter 
profiles (as  a  surrogate index for cell  size).  (/3) CD3  expression.  (C) 
CD4/CD8  dual parameter flow cytometric profiles document increased 
representation of immature CD4-/CD8-  cells. 
ulocytes (6, 43). We have previously demonstrated that sub- 
stitution of phenylalanine for tyrosine at position 501 yields 
an especially potent transforming gene when tested in NIH 
3T3 cell transfection assays (35). A hck cDNA bearing the 
appropriate mutation was inserted into the p1017 vector (Fig. 
1 C) which comprises a 3.2-kb kk proximal promoter frag- 
ment linked to the human growth hormone (hGH)  gene 
which provides intronic structure, a polyadenylation signal, 
and a unique Y-untranslated region (33, 34). With this vector 
system, transcript levels of the hck transgene could be directly 
compared with those observed with the/ck transgenes since 
each incorporates the same 3' untranslated region. 
Results obtained through examination of eight indepen- 
dent founder animals and two lines of hckF501 animals are 
summarized in Table 2. Expression of the hckF501 transgene 
failed to produce any tumors or phenotypic abnormalities 
in developing thymocytes in spite of the fact that transgene 
mKNA expression levels were, in at least one case, as high 
as those observed in kkF505 tumor-bearing lines (Table 2). 
There were also no discernible  abnormalities in peripheral 
T cells (Table 2 and data not shown). Flow cytometric anal- 
),sis revealed patterns of CD4, CDS, and CD3 staining that 
were indistinguishable from control animals for both thymo- 
cytes and mature peripheral T cells (data not shown) in spite 
of the fact that the hck protein, not normally present in thymo- 
cytes, was readily detectable in extracts from hckF501  thymo- 
cytes (Fig. 9). We conclude that simple augmentation of the 
levels of a src-family protein tyrosine kinase in developing 
thymocytes is not sufficient to provoke either tumorigenesis 
or developmental perturbations. Hence the effects observed 
with the kk transgenes reflect some unique activity of p56  ~k 
that is independent of its ability to interact with the CD4 
and CD8 coreceptors. 
transgenic (kkFS05A20,23  x  CD4) mice. The failure to rescue 
CD3 + cells in kkF505A20,23 mice with the kk-CD4 trans- 
gene demonstrates that pSC  ~Fs~176  fails to associate with 
CD4 in vivo (as expected), and that the attenuation of the 
effects of the kkF505 transgene in mice simultaneously over- 
expressing CD4  is  due to  the interaction of p56  kk with 
CD4, which in this case suppresses, rather than stimulates, 
a kinase-mediated signaling process. 
Specificity of kkF505 Induced Abnormalities.  Thymocytes 
contain numerous protein tyrosine kinases besides p56  uk (2, 
6, 42). Since the developmental perturbations induced by kk 
overexpression occurred independently of its association with 
the CD4/CD8 coreceptors, it was possible that these abnor- 
malities might result from a nonspecific effect of augmented 
protein tyrosine kinase activity.  To investigate this hypoth- 
esis, we generated constructs in which a closely related src- 
family  kinase,  p59  h'k, in  an  activated  form  lacking  the 
regulatory COOH-terminal tyrosine (hckF501), was expressed 
under the control of the same kk proximal promoter element. 
The hck gene product is not normally found in thymocytes, 
but is present in cells of the myeloid lineage, especially gran- 
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Discussion 
p56~k: A  Unique Regulator of ThTmocyte Maturation.  The 
experiments reported above were initiated in an attempt to 
define the mechanism whereby expression of high levels of 
p56  ~k perturbs the normal thymocyte maturation sequence. 
Previous studies permitted us to construct a dose-response 
curve for the effects of augmented p5C  k activity,  and re- 
vealed that even very modest augmentation of the level of 
wild-type p56  ~k protein, expressed under the control of its 
own transcriptional  regulatory elements, resulted in very sub- 
stantial developmental abnormalities (29). Subsequent inves- 
tigation revealed that the most prominent feature of this 
maturational arrest, the inability to generate CD3 § thyrno- 
cytes, resulted from a single molecular defect: the failure to 
catalyze VB-Dfl joining and hence the inability to produce 
a functional TCR fl chain (30). The exquisitely specific na- 
ture of this abnormality suggested that  augmentation of 
p56  ~k activity impinged on a normal regulatory process in- 
volved in controlling TCR gene rearrangement. However, 
in light of the fundamental regulatory roles of protein tyro- 
sine kinases generally, it was possible that the developmental 
block induced by overexpression  of p56  ~  might be non- 7137  4965  5049 
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Figure  3.  Increased kkF505A20,23 
transgene expression corrdated with the 
degree of abnormality observed in CD4 
x  CD8 profiles.  Thymocyte CD4  x 
CD8  two-parameter profiles  for rep- 
resentative  animals  in  each  of eight 
lines of mice (see Table 1 for expres- 
sion values). Profiles are arranged from 
highest expression  level to the lowest. 
(Control)  Results of this analysis per- 
formed  using  cells  from  a  control 
thymus. 
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Figure  4.  Expression  of the kkF505A20,23  transgene  affected devel- 
opment of CD3 + cells with the same potency as the kkF505 transgene. 
(x-axis) Transgene expression is plotted as pg of transgene mRNA per 
#g of total KNA. (y-axis) Number of CD3 + cells (as percentage  of con- 
trol values). Results obtained using animals expressing the kkF505A20,23 
transgene  (-A-)  are compared with values previously reported  (29) for 
kkF505 mice (-O-). The level of mRNA that corresponds to endogenous 
kk transcript  abundance  in this assay is indicated  (=12  pg/#g). 
specific, the result of hyperstimulation of a regulatory mech- 
anism that  need not, under normal circumstances,  involve 
p56 ~k itself at all. 
Whereas we cannot exclude this argument completely,  the 
results  reported  here, coupled with other studies,  serve to 
focus  attention  on  p56 ~k  as  a  unique  regulator  of early 
thymocyte maturation.  First, p56  uk is ordinarily  expressed 
at highest levels in immature thymocytes (2, 5-7). This con- 
trasts with other nonreceptor protein tyrosine kinases, notably 
p59f~  T, which are expressed at highest levels in mature  T 
lineage cells (33). Second, although thymocytes are extraor- 
dinarily  sensitive  to  the presence  of augmented levels  of 
p56 ~,  simple overexpression  of other nonreceptor  protein 
tyrosine kinases does not appreciably alter early thymocyte 
maturation.  For example, overexpression of p59f~ under the 
control of the proximal kk promoter yields animals with T 
cells that respond inordinately vigorously to stimulation of 
the TCK, but the thymocytes from these animals mature nor- 
mall), (33). In the present study, we used the same promoter 
element  to  express  p59  ~k,  a myeloid  cell-specific  protein 
tyrosine kinase ordinarily expressed at highest levels in gran- 
250  p56  ~  Acts Independently of CD4/CD8  T  Cell Development Figure  6.  p56kkrs~  23 failed to associate with CD4 in thymocyte ex- 
tracts. Detergent extracts were prepared (see Materials and Methods) from 
thymocytes isolated from a normal mouse (N/-~, from an animal of the 
kkF505 3073 line (29), or from an animal of the kkF505A20,23 7120 line. 
Immunopreeipitations were  performed using either  an  anti-p56  ~k an- 
tiserum or an anti-CD4 mAb. In vitro kinase activity was assayed using 
these immune complexes,  and the products were subsequently resolved 
on 10% SDS-PAGE. Autophosphorylation of p56 kk and phosphorylation 
of enolase were measured by quantitation of 52p incorporation using a Mo- 
lecular Dynamics Phosphotimager.  These values (bottom)  are expressed rel- 
ative  to  those  obtained  using  immunopreeipitates  from  the  normal 
thymocytes. 
Figure  5.  Thymocytes from kkFS05A20,23 mice were deficient in Vfl 
rearrangements and mature TCR-fl transcripts but produced normal levels 
of TCR-ot transcripts. (.4) Total thymocyte RNA was prepared from a 
normal mouse (NLC), from two lines of khFS05 mice,  and from four 
lines of kkF505A20,23 animals. 10 #g of each RNA sample was separated 
on a 1% agarose/formaldebyde  gel, blotted onto a nylon filter, and probed 
for Cfl- (top) or Ca- (bottom) containing transcripts. Two Cfl transcripts 
were observed: an immature 1.0-kb form which represents  transcription 
initiating adjacent to rearranged Dfl elements, and the mature 1.3-kb tran- 
script originating from VflD~I~ rearranged DNA. Only the immature 
transcript was present in all transgenic animals except for the kkF505A20,23 
4972  line which expressed very little of the transgene mRNA and pro- 
duced normal numbers of CD3 § cells (see Table 1). A single 1.6-kb ma- 
ture Cc~ transcript was observed and this was present at roughly the same 
levels in all thymocyte RNA samples examined.  (/3) Vfl8 (top) and Dfl2 
(bottom) rearrangements to J~2 segments were amplified by PCR using 
thymocyte DNA from the indicated normal or transgenic animals. Specific 
rearrangements in tramgenic thymocytes are reduced in abundance by >80% 
as compared with control thymocytes. 
ulocytes.  In fibroblast transformation  assays, p59  hckvs~ exhi- 
bits  100-fold more transforming  activity than does p56  ~kFs~ 
(35).  Yet,  thymocytes  tolerate high level expression of this 
potent  transforming  gene with  impunity  (Table 2).  Hence 
p56  k~  acts  uniquely  in blocking  thymocyte  maturation. 
It should also be noted that mice lacking a functional  Ick 
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Figure  7.  Expression  of a CD4 transgene rescued  CD3 + thymocyte 
development in kkF505 mice. Animals of the kleF505 2954 line (29) were 
crossed to the kk-CD4 727 line (41). Shown here are representative  ex- 
amples of CD3 histograms of thymocytes from progeny of a single cross. 
CD3 fluorescence is plotted versus relative cell number.  The genotype of 
each animal is shown above the profile and the percentages  of cells ex- 
pressing CD3 at high and low densities are indicated. 
gene exhibit a distinct, but nevertheless severe, defect in thymo- 
cyte maturation consisting of a marked decrease in total thymo- 
cyte number  with  relative preservation  of the  most  imma- 
ture  (CD4-8-)  cells (27).  We have obtained similar results 
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Figure  8.  Expression of a CD4 transgene failed to rescue CD3 + thy- 
mocyte development  in mice expressing the kkF505A20,23 transgene. Mice 
from  the  kk-CD4  727  line (41) were  crossed to  those  from  the 
kkF505A20,23 7120 line, and thymocyte CD3 histograms from progeny 
of a single cross are presented. Each animal's genotype is given (top) and 
the percentages of cells expressing CD3 at high and low densities are in- 
dicated. 
using  an  Ick transgene  that  encodes  a  catalytically inactive 
form of pSC  ~. As the level of this protein increases,  thymo- 
cyte production becomes progressively attenuated (28). Thus, 
the catalytically inactive form of p5C  k acts as a  dominant- 
negative inhibitor  of p56  ~k function.  Intriguingly,  the thy- 
mocytes from animals bearing high levels of catalytically in- 
Figure  9.  Expression of p59  I'~ in 
thymocyte  extracts  from  hckF501 
transgenic mice. Cell extracts were 
prepared  from  normal  thymocytes 
(NLC), from hckF501-expressing  thy- 
mocytes (HYF 2173), or from NIH 
3T3 cells transfected  with an/~kP501 
cDNA under transcriptional control 
of the metallothioein I promoter (MT 2.1) (53). 40 #g of total protein 
was resolved on 12% SDS-PAGE, transferred to nitrocellulose, and de- 
tected with an hck-specific  antiserum. (-~) Position of p59  h'k. There is also 
a slightly smaller unidentified crossreacting band in aU lanes. 
active  p56  ~k  support  normal  levels  of V~  gene  rearrange- 
ment (28).  These observations have prompted us to suggest 
that  p56  ~  normally  promotes  thymocyte  maturation  by 
sensing the correct  synthesis of a TCK/~ chain,  and  there- 
after by directing that further rearrangements at the ~  locus 
cease and that cell replication proceed (28, 30).  When p5C  k 
is overexpressed in an active form, thymocytes are generated 
that appear to have received these signals inappropriately.  In 
these cells,  VB rearrangement  is  attenuated  before satisfac- 
tory assembly of a  functionally  rearranged  TCR  ~  gene  is 
complete.  Although  the specific targets of p56  ~k action re- 
main undefined,  it  is  apparent  that  the/ck-encoded  kinase 
acts relatively uniquely  to  deliver  this  signal,  and  that  the 
signaling process requires protein tryosine kinase activity, since 
catalytically  inactive  p56 ~  does  not  promote  the  same ef- 
fects  (28). 
Nature of the Signaling Structure that Activates p56t~k  Al- 
though the general function of src-family kinases remains mys- 
terious,  it is believed that  these molecules assist in relaying 
signals from the cell surface to the cell interior.  This conclu- 
sion derives in large part from the study of p56  ~k and p59fr" 
in lymphocytes. The hematopoietic isoform of p59~ (p59fr,T) 
Table  2.  Summary of Results Obtained  from  hckFSOl Transgenic Mice 
Transgene  Tumor  CD3 §  CD3 + 
Line  Number  Expression  mKNA  p59  *'~  Formation  (Thymus)  (Periphery) 
2169  1  23.5  +  ND  -  98  86 
1637  1  ND  +  +  -  100  93 
1629  1  ND  +  +  -  119  107 
2186  1  ND  ND  ND  -  99  105 
2189  1  ND  ND  ND  -  94  105 
2173  1  ND  ND  +  -  96  113 
2167  1  2.3  +  ND  -  ND  ND 
13853  1  ND  ND  +  -  95  134 
2171  3  ND  +  ND  -  107  ND 
2195  3  ND  ND  +  -  100  ND 
Expression values are reported as pg of transgene mKNA/#g of total KNA. Specific  detection of transgene mKNA or p59  h'k when not quantitated 
is also noted. The number of CD3 § thymocytes and peripheral T cells is given as percentages of normal littermate control values. Tumor formation 
was judged  by the same criteria as in Table 1. 
252  p56  ~k Acts Independently of CD4/CD8 T  Cell Development interacts physically and functionally with the CD3 complex 
on T  lymphocytes (33,  44-46),  and loss  of p59fv' blocks 
antigen-induced signal transduction to a large extent, espe- 
cially in mature thymocytes (45, 46). In contrast, p56  ~k ap- 
pears to interact with at least three, and perhaps more receptor 
structures.  A  unique  motif in  its  NH2-terminal  domain 
confers upon it the ability to interact with the CD4 and CD8 
coreceptors (17, 18), while its kinase domain can associate 
physically and functionally with the IL-2 receptor ~/chain 
(47). A recent report also documents the presence of p56  ~t 
in immunoprecipitates formed using antisera to a variety of 
T cell surface proteins linked via a phosphatidylinositol-glycan 
moiety to the cell membrane (48). 
In principle, any or all of these receptor structures might 
stimulate p56  ~t to suppress thymocyte development. How- 
ever, our data make plain that these signals do not arise from 
CD4 or CD8.  In fact,  augmented expression  of CD4 ap- 
pears to sequester p56  ~k and prevent it from blocking VB 
gene rearrangement (Fig. 7). Thus animals of the 2954 kkFS05 
line, expressing approximately 12 pg/#g of transgene-derived 
transcript, behave more like those of the 3073 line, expressing 
6 pg/lzg of transgene mRNA (29),  when a 15-fold excess 
of CD4 is present (Fig. 7 and data not shown). The inability 
of excess CD4 to rescue CD3 expression in thymocytes bearing 
an kkF505A20,23 transgene demonstrates the importance of 
the p56  ~k cysteine motif in permitting CD4 to ameliorate 
the untoward effects of kinase overexpression.  We have pre- 
viously noted that expression of augmented levels of CD4 
appeared to sequester endogenous p56  ~k and block signaling 
in an antigen-specific  thymocyte selection system, and that 
this ability depended upon the presence of the cytoplasmic 
tail of CD4 which contains a p56~k-binding motif (41, 49). 
Similarly, Haughn et al. have proposed that sequestration of 
p56  ~k by CD4 can explain the nonresponsiveness induced in 
a CD4-  OVA-specific T  cell line after expression  of retro- 
viraUy encoded wild-type CD4 protein (50). Thus although 
CD4-mediated signaling in antigen-specific T cell lines may 
require interaction with p56  ~k (19), potentiation of p56  ~- 
mediated responses  is not dependent solely on CD4. 
We can similarly conclude that the IL-2 receptor, though 
capable  of binding p56  ~k,  probably does  not  activate  its 
ability to arrest thymocyte development. First, p59fw can be 
shown to bind to the IL-2 receptor ~ chain and to be acti- 
vated by IL-2 (51), and yet overexpression of p59fw does not 
influence early thymocyte development (33).  Second,  mice 
lacking IL-2 as a result of a targeted gene disruption display 
no abnormalities in thymocyte maturation. In light of these 
observations, and since p56  ~  expression is both required for 
normal  thymocyte development,  and  incompatible with 
normal thymocyte development if it exceeds routine levels 
to any great extent, we conclude that p56  ~k must ordinarily 
act through interactions with a receptor structure that is nei- 
ther CD4, CDS, nor the IL-2 receptor ~ chain. In this con- 
text, it is important to note that p56  ~k appears to promote 
signaling from the TCK itself in both a murine system, where 
overexpression of p56  ~k improves antigen-specific  responses 
in the complete absence of coreceptor expression  (23),  and 
in a human T  cell tumor line, where loss of p56  ~k expres- 
sion blocks TCK signaling (24). These observations are com- 
patible  with  the  view  that  p56  ~  functionally  couples 
directly to the TCR-CD3 complex in mature T  cells and 
thus could also do so during thymocyte development to sense 
the correct assembly of some portion of the TCR complex 
that depends upon ~ chain expression,  but does not require 
either CD4 or CD8. 
Selective Functions  of m-Family Protein Tyrosine  Kinases.  The 
src-family protein tyrosine kinases are expressed in special- 
ized forms in hematopoietic cells (2, 52). Indeed, 5/8 of these 
kinases (blk,fgr, hck, Ick, and lyn) are expressed only in blood 
cells, and thefyn gene encodes two distinct proteins, one of 
which is hematopoietic cell specific (52). The effects of p56  ~k 
on thymocyte  development illustrate an emerging general prin- 
ciple: these nonreceptor kinases, even when expressed simul- 
taneously in single cells, perform highly specialized signaling 
functions. Thus loss offyn  gene expression  yields thymo- 
cytes that mature satisfactorily but fail to transmit normal 
TCK-derived activation signals (45, 46). In contrast, loss of 
/ck gene expression blocks normal thymocyte development 
almost completely (27). Our studies of the effects of p56  ~k 
overexpression add a further dimension to this analysis. Other 
src-family kinases, though similar in overall configuration and 
in their ability to phosphorylate substrates  in vitro, simply 
cannot deliver a signal that suppresses B chain gene rearrange- 
ment.  Definition of the structural features  of p56  ~t  that 
endow it with its functional attributes should provide clues 
for the identification of molecules, both receptors and effectors, 
that regulate the development of T  lymphocytes. 
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